Legionella Manipulates Non-canonical SNARE Pairing Using a Bacterial Deubiquitinase.
COPI
Legionella
SNARE
Sec22b
deubiquitinase
early secretory pathway
effector protein
syntaxin
type IV secretion system
ubiquitin
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
08 09 2020
08 09 2020
Historique:
received:
19
10
2019
revised:
30
05
2020
accepted:
12
08
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
29
5
2021
Statut:
ppublish
Résumé
The intracellular bacterial pathogen Legionella pneumophila uses many effector proteins delivered by the bacterial type IV secretion system (T4SS) to hijack the early secretory pathway to establish its replicative niche, known as the Legionella-containing vacuole (LCV). On LCV biogenesis, the endoplasmic reticulum (ER) vesicular soluble N-ethylmaleimide-sensitive factor attachment protein receptors (v-SNARE) Sec22b is recruited to the bacterial phagosome and forms non-canonical pairings with target membrane SNAREs (t-SNAREs) from the plasma membrane. Here, we identify a Legionella deubiquitinase (DUB), LotB, that can modulate the early secretory pathway by interacting with coatomer protein complex I (COPI) vesicles when ectopically expressed. We show that Sec22b is ubiquitinated upon L. pneumophila infection in a T4SS-dependent manner and that, subsequently, LotB deconjugates K63-linked ubiquitins from Sec22b. The DUB activity of LotB stimulates dissociation of the t-SNARE syntaxin 3 (Stx3) from Sec22b, which resides on the LCV. Our study highlights a bacterial strategy manipulating the dynamics of infection-induced SNARE pairing using a bacterial DUB.
Identifiants
pubmed: 32905772
pii: S2211-1247(20)31096-2
doi: 10.1016/j.celrep.2020.108107
pii:
doi:
Substances chimiques
Bacterial Proteins
0
Deubiquitinating Enzymes
EC 3.4.19.12
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108107Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare no competing interests.